scispace - formally typeset
J

Jackson Thomas

Researcher at University of Canberra

Publications -  72
Citations -  1539

Jackson Thomas is an academic researcher from University of Canberra. The author has contributed to research in topics: Pharmacist & Systematic review. The author has an hindex of 16, co-authored 68 publications receiving 1128 citations. Previous affiliations of Jackson Thomas include University of Tasmania.

Papers
More filters
Journal ArticleDOI

Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section

TL;DR: It is recommended that bolus doses should be used with caution, and further studies should ascertain if oxytocin is equally effective in reducing blood loss when given at a slower rate.
Journal ArticleDOI

Toenail onychomycosis: an important global disease burden

TL;DR: In patient populations such as diabetic individuals, where onychomycosis can provoke lower extremity complications, professional podiatry care of toenails and feet should be encouraged.
Journal ArticleDOI

When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19.

TL;DR: This commentary aims to summarise the existing literature in relation to the promising treatments currently under trial, the perils of falsified medications and medicine-related information and the role of pharmacists in taking a leading role in combating these parallel global emergencies.
Journal ArticleDOI

Scabies: an ancient global disease with a need for new therapies

TL;DR: The emergence of resistance among scabies mites to classical scabicides and ineffectiveness of current treatments (in reducing inflammatory skin reactions and secondary bacterial infections associated with scabies), raise serious concerns regarding current therapy.
Journal ArticleDOI

Chemotherapy in Pancreatic Cancer: A Systematic Review

TL;DR: There is a need to develop further strategies besides chemotherapy to improve the outcomes in pancreatic cancer treatment and future studies should consider surgical interventions, combination chemotherapy, and individualized second-line treatment based on the prior chemotherapy.